Breaking News

Royalty Pharma Adds to Management Team

July 19, 2013

Urist to serve as vice president of research and investments

Marshall Urist, MD, Ph.D., has been named vice president of Research and Investments at Royalty Pharma. Dr. Urist joins the company from Morgan Stanley, where he spent the last eight years at in equity research, most recently as executive director and senior biotechnology analyst covering the life science tools and diagnostics sectors. 
 
"We are excited to have Marshall join our team. He has had a distinguished career on Wall Street, and this experience coupled with his deep analytical skills make him an excellent addition to Royalty Pharma," said Pablo Legorreta, founder and chief executive officer of Royalty Pharma.

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry